Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gamma-glutamyltransferase 2, pseudogene (GGT2P) is a human pseudogene that appears to be a duplication of the gamma-glutamyltransferase 1 (GGT1) gene. Although GGT2P and GGT1 can potentially encode highly similar proteins, GGT2P lacks the ability to undergo necessary autocatalytic cleavage, resulting in the lack of a mature, enzymatically active protein. As a pseudogene, GGT2P is expressed at much lower levels than GGT1 and does not produce a functional enzyme. It is not considered a therapeutic target and has no established role in biological function, disease association, drug interaction, biomarker utility, or safety concerns
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-glutamyltransferase 2, pseudogene (GGT2P).